Sonnet BioTherapeutics Holdings (SONN) Financials
SONN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 5.3 million | 2.8 million |
| 2023-09-30 | 5.4 million | 5.7 million |
| 2023-06-30 | 10.0 million | 6.6 million |
| 2023-03-31 | 13.3 million | 7.9 million |
SONN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -3.1 million | 50005 |
| 2023-09-30 | -4.7 million | 50006 |
| 2023-06-30 | -6.2 million | 50005 |
| 2023-03-31 | -5.0 million | 56998 |
SONN Net Income
No data available :(
SONN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 3.0 million | - | 186686 |
| 2023-09-30 | 2.3 million | - | 203911 |
| 2023-06-30 | 7.0 million | - | 220631 |
| 2023-03-31 | 11.4 million | - | 236859 |
SONN Shares Outstanding
SONN Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | 624068 | 653455 | - |
| 2023-09-30 | 170000 | 1.8 million | 1.8 million | - |
| 2023-06-30 | 12000 | 2.4 million | 1.5 million | - |
| 2023-03-31 | 261249 | 3.8 million | 1.9 million | - |
SONN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 18626 | 19974 |
| 2023-09-30 | 37255 | 19466 |
| 2023-06-30 | 36850 | 18977 |
| 2023-03-31 | 36445 | 18873 |
SONN
Price: $1.75
52 week price:
Earnings Per Share: -0.83 USD
P/E Ratio: -0.08
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 442053
Market Capitalization: 5.8 million